• share
• favorite_border

The Association for Research in Vision and Ophthalmology (ARVO) urges Congressional leaders to reject the U.S. administration’s recent FY18 budget proposal, which seeks to drastically cut National Institute of Health funding by nearly $6 billion, or 20%. These cuts would be devastating to the current and future efforts of the eye and vision research community and to patients who desperately count on the efforts of researchers and clinicians to save their sight.

• share
• favorite_border

• share
• favorite_border

e Association for Research in Vision and Ophthalmology (ARVO) has joined with other scientific societies in partnering with the March for Science, a mass outpouring of non-partisan support for science and the scientific community.

• share
• favorite_border

Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness. Researchers have determined from which direction collisions with partially blind pedestrians are most likely to originate. This understanding will guide the development of new glasses that expand the sight of a person with limited peripheral vision.

• share
• favorite_border

Scientists have found that with minimal training, members of the general public may be able to match the accuracy of experts in interpreting medical images of the eye. The work, published in Translational Vision Science & Technology (TVST), introduces a world where individuals without medical training could contribute to decisions made in the clinic.

• share
• favorite_border

To celebrate its revolutionary impact on eye care around the world, the Associatio n for Research in Vision and Ophthalmology (ARVO) has independently produced a series of short videos, educational tools and advocacy resources on the discovery and development of optical coherence tomography (OCT).

• share
• favorite_border

To provide a better view of difficult to see tissue, Japanese researchers have miniaturized an imaging probe to fit inside a needle that can be inserted into the eye during eye surgery. The probe was used without complications in three human patients, as described in an article published in Investigative Ophthalmology & Visual Science (IOVS).

• share
• favorite_border

The journal Investigative Ophthalmology & Visual Science (IOVS) is commemorating the 25th anniversary of the development of optical coherence tomography (OCT) with the release of a special issue of more than 70 papers from authors on five continents.

• share
• favorite_border

Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ― in the back of the eye ― progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science ( IOVS).

• share
• favorite_border

A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements. The paper, “Development and learning of saccadic eye movements in 7-42 month-old children” was published in the Journal of Vision.

• share
• favorite_border

Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer’s disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

Building on existing evidence, vision researchers have found that limiting exposure to blue light after sunset increases the quality and length of sleep. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

Pterostilbene (PS), a component of blueberries, have been found to protect against dry eye disease according to a new study. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

Researchers have safely transplanted stem cells derived from a patient’s skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

Scientists have successfully implanted a prosthesis that restores some central vision in patients with only limited peripheral vision remaining to them – the first time artificial and natural vision has ever been integrated in humans. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

According to new research, injection of 3-hydroxybutyrate (3HB) offers similar protection as a low calorie diet against nerve degeneration in rats with glaucoma. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

• share
• favorite_border

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries. Two free events will feature speakers highlighting recent successes — and emerging threats — facing ophthalmic clinicians and researchers around the world.

• share
• favorite_border

This ARVO Meeting showcases cutting-edge eye and vision science and an early glimpse into the latest advances in potential treatments for eye disease and blindness — often years ahead of their introduction to the clinic.

• share
• favorite_border

What and Why: Vision and Traumatic Brain Injury (TBI): A view toward therapeutics More than 75% of all TBI patients experience visual disorders, including double vision, light sensitivity, difficulty reading print and even vision loss. This interactive session will bring together some of the best minds studying TBI to discuss two important topics: what happens inside the head and eyes of a patient with TBI that leads to symptoms, and the scientific exploration that gives hope for treatments for the debilitating condition.

• share
• favorite_border

There is good news for frequent public speakers. New research shows that individuals have the ability to quickly and accurately identify a crowd’s general emotion as focused or distracted, suggesting that we can trust our first impression of a crowd’s mood. The paper,Mixed emotions: Sensitivity to facial variance in a crowd of faces was recently published in the Journal of Vision.

• share
• favorite_border

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science (IOVS), the findings indicate that treatments currently used for other conditions could also work for dry AMD.

• share
• favorite_border

To honor the memory of a longtime leader in glaucoma treatment and research, the ARVO Foundation for Eye Research will present the Dr. David L. Epstein Award. The new award — a $100,000 prize — was established by the late Dr. Epstein's family and will be presented annually to a senior-level glaucoma researcher at the ARVO Annual Meeting. The first award will be given at ARVO 2016 in Seattle, Wash.

• share
• favorite_border

A new study may have unlocked understanding of a mysterious part of the brain — with implications for neurodegenerative conditions such as Alzheimer’s. The results, published in Translational Vision Science & Technology (TVST), open up new areas of research in the pursuit of neuroprotective therapies

• share
• favorite_border

On May 7, researchers are reporting a case study in which viable Ebola virus was present in the eye’s aqueous humor — the clear fluid in the front of the eye, between the lens and the cornea — 10 weeks after the virus was no longer detectable in the patient’s blood.

• share
• favorite_border

Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Preterm babies with retinopathy of prematurity (ROP) treated using bevacizumab, a growth inhibitor, have been found to have lower motor scores than babies treated with traditional laser ablation. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have developed a new computer model to describe how cholesterol deposits, known as drusen, behave in the retina in the dry form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Scientists have found that baicalein significantly lowers eye pressure and may act as an all-natural treatment for glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

L-DOPA, a routine drug taken by patients suffering from Parkinson’s disease, has been found to delay the onset of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have identified a new target for stopping the progressive death of cells in the eye that leads to vision loss in glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have found that blocking the connections between cells in the retina can prevent toxins in one cell from spreading – and killing – its neighbors. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Col

• share
• favorite_border

A new study found that eye drops were just as effective as eye injections for treating the wet form of age-related macular degeneration (AMD). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Paving the way for drug discovery efforts, researchers have found a target that – when inhibited – reduces inflammation associated with vision loss in patients with diabetic retinopathy (DR). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Scientists have identified new biomarkers that could distinguish Sjögren’s Syndrome (SS) from other autoimmune diseases in days or weeks, improving on a current time to diagnosis of four-plus years. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo

• share
• favorite_border

A new study finds that when cells in the eye do not have enough oxygen, they improperly sort proteins, an issue that has been implicated in age-related macular degeneration (AMD) and Alzheimer’s disease. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers found that 70% of patients received a dose of hydroxychloroquine that exceeded safety guidelines, and can potentially cause vision loss, in an inner city hospital. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Risk of developing age-related macular degeneration higher in patients with AIDS Denver, Colo. – Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV, according to results from the Longitudinal Study of the Ocular Complications of AIDS (LSOCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Scientists suggest exosomes released by the eye help speed up the drainage of fluid — offering another avenue to treat glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have identified a genetic link between schizophrenia and strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have determined that the three-dimensional organization of DNA in photoreceptor cells plays a crucial role in their function. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Investigators have discovered a new class of drugs that may more effectively treat retinoblastoma, a cancer of the retina that develops in children. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Shifting detection to even earlier than currently used tests, scientists have used vection to identify mild glaucoma. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

• share
• favorite_border

Researchers have developed a new method of purifying stem cells that is faster, more efficient and less expensive than current methods for treating diseases of the retina. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo. The new stem cell purification process involves growing stem cells on a special chip containing a computer system. Each stem cell is monitored closely, and the lower quality cells are removed as soon as they are identified.